Roth/MKM Starts ARS Pharmaceuticals Inc (SPRY) at Buy, 'Game Changer for the Epinephrine Market'
Tweet Send to a Friend
(Updated - September 4, 2025 9:27 AM EDT)
Roth/MKM analyst Jason Wittes initiates coverage on ARS Pharmaceuticals Inc (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Roth/MKM analyst Jason Wittes initiates coverage on ARS Pharmaceuticals Inc (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
